Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines (Q30382146)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines |
scientific article |
Statements
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines (English)
Claire-Anne Siegrist
Nick Andrews
Julia Stowe
Elizabeth Miller
Neal Halsey
Juhani Eskola
Claudia Vellozzi
Steven Black
Barbara Law
Kirsten Vannice
Hector S Izurieta
Aysha Akhtar
Mike Gold
Gabriel Oselka
Dina Pfeifer
Noni MacDonald
31 October 2009